Author： Walker Damian Stevens Warren
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.3, 2003-03, pp. : 359-368
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is DOTS-plus worth it for TB in developing countries?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 404, 2003-01 ,pp. :
Access to resources
Recommend
Funding boost for control programmes in developing countries
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. :
Affordable IVF for developing countries
Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. :
New framework for TB control in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 361, 2002-01 ,pp. :
New framework for TB control in Europe
Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. :